Sangamo Therapeutics: Communiqué Normé Related to the Offeror’s Draft Prospectus Related to the Simplified Public Tender Offer Targeting the Shares of the Company Oct 2, 2018 09:24AM
Sangamo and TxCell announce the completion of the acquisition by Sangamo of majority of TxCell ordinary shares Oct 1, 2018 08:00AM
Sangamo and TxCell Announce the Completion of the Acquisition by Sangamo of Majority of TxCell Ordinary Shares Oct 1, 2018 08:00AM
Sangamo Therapeutics to Acquire TxCell Jul 23, 2018 02:30AM
Sangamo Therapeutics to Acquire TxCell Jul 23, 2018 02:30AM


Apr 26, 2018 12:36PM TxCell Announces That All Management Resolutions Supported by the Board of Directors Were Approved with More Than 94% During Its Annual Meeting of Shareholders